Question explored with the scientific record
Conversation so far
- 1 Amoxcillin + Clavunic acid
- 2 How do guidelines recommend treating acute bacterial sinusitis?
- 3 Is Amoxcillin + Clavunic acid safe in a 7 day dose?
Answered on this page ↓
Is Amoxcillin + Clavunic acid safe in a 7 day dose?
The short version: a 7-day course of amoxicillin-clavulanate is effective for bacterial sinusitis, but the safety data shows real risks you should weigh.
The retrieved evidence shows this antibiotic works. In adults with acute bacterial sinusitis, a 7-day course of amoxicillin-clavulanate 875/125 mg produced significant symptom improvement, similar to inhaled alternatives [8]. A 2006 manufacturer-funded study of 1,678 patients reported 87.8% bacteriologic success, with diarrhea in 16.5% and 2.2% withdrawing due to side effects [9, 10].
For children, a 10-day course was similar in efficacy to a 3-day azithromycin course, with no severe adverse reactions attributed to either [5]. In acute otitis media studies, amoxicillin-clavulanate caused more gastrointestinal side effects (39% vs 18%) and diaper rash than alternatives [3, 7].
The serious side effects are rare but real. Italian reporting data found amoxicillin-clavulanate caused more liver damage (4% of reports) and Stevens-Johnson syndrome than amoxicillin alone [1]. A 2024 case report describes severe toxic epidermal necrolysis after the drug [2], and another describes severe cholestatic liver injury in an 80-year-old woman [4]. These are documented, not hypothetical.
The evidence does not include a direct safety comparison of a 7-day course against longer or shorter courses for sinusitis specifically. Most sinusitis trials used 10-day courses. A 5-day regimen was shown non-inferior to 7 days for chronic bronchitis [6], but that is a different disease.
For a typical patient, the most common side effects are diarrhea (about 1 in 6), nausea, and skin rash. Serious liver injury or severe skin reactions are rare but possible. The 7-day duration is standard and supported, but not rigorously safety-tested against shorter courses for sinusitis.
My call: amoxicillin-clavulanate is effective for bacterial sinusitis but carries real, documented risks including diarrhea, liver injury, and severe skin reactions. In children, alternatives cause fewer side effects. Confidence: moderate for efficacy; moderate for safety risks being real, though low for the exact 7-day sinusitis-specific incidence.
Sources used 10
-
Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy
This study analyzes adverse drug reactions reported in Italy to compare the safety profiles of amoxicillin and amoxicillin/clavulanic acid, revealing that the latter is associated with a higher risk of serious adverse effects, particularly liver damage and Stevens-Johnson syndro…
DOI: 10.1093/jac/dkm111 -
AMOXICILLIN+ CLAVULANIC ACID INDUCED TOXIC EPIDERMAL NECROLYSIS (TEN)
A case report describes a patient who developed toxic epidermal necrolysis after treatment with amoxicillin-clavulanic acid (Augmentin), with causality assessed as possible using the WHO-UMC scale and severity rated as severe.
DOI: 10.5455/jhspe.20240703060939 -
Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children
In children with acute otitis media with effusion, cefuroxime axetil produced clinical outcomes equivalent to amoxicillin-clavulanate and fewer drug-related adverse events.
DOI: 10.1128/aac.38.2.315 -
Severe hepatic cholestasis after treatment with amoxicillin/clavulanic acid
This case report describes an 80-year-old woman with amoxicillin-clavulanate-induced liver injury, a rare adverse reaction typically presenting as cholangiopathy with cholestasis.
DOI: 10.61409/v02240094 -
Azythromicin Versus Amoxicillin-clavulanate in the Treatment of Acute Sinusitis in Children
In children with acute sinusitis, a 3-day course of azithromycin showed similar efficacy to a 10-day course of amoxicillin-clavulanate, with no significant differences and no severe adverse reactions attributable to either agent.
DOI: 10.17305/bjbms.2006.3127 -
Efficacy and Safety of Pharmacokinetically Enhanced Amoxicillin-Clavulanate at 2,000/125 Milligrams Twice Daily for 5 Days versus Amoxicillin-Clavulanate at 875/125 Milligrams Twice Daily for 7 Days in the Treatment of Acute Exacerbations of Chronic Bronchitis
In a randomized trial of patients with acute exacerbations of chronic bronchitis, a 5-day course of amoxicillin-clavulanate 2000/125 mg was at least as effective clinically as a 7-day course of 875/125 mg, with similar safety.
DOI: 10.1128/aac.49.1.153-160.2005 -
Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media
In children with acute otitis media, loracarbef and amoxicillin-clavulanate produced satisfactory clinical outcomes; recurrent AOM was not significantly different between treatments, but diaper rash was less common with loracarbef.
DOI: 10.1128/aac.35.5.967 -
The inhalation antibioticotherapy of acute bacterial rhinosinusitis
In an open randomized parallel-group trial, 60 adults with moderate acute bacterial rhinosinusitis receiving either topical pulsed inhalation with thiamphenicol glycinate N-acetylcysteinate via Pari Sinus or oral amoxicillin/clavulanate both showed significant symptom improvemen…
DOI: 10.21518/2079-701x-2018-20-50-54 -
Efficacy/safety of amoxicillin/clavulanate in adults with bacterial rhinosinusitis
This study evaluates the efficacy and safety of a pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in treating adults with acute bacterial rhinosinusitis, demonstrating high rates of bacteriologic and clinical success, particularly against resist…
DOI: 10.1016/j.amjoto.2005.11.015 -
Pharmacokinetically Enhanced Amoxicillin/Clavulanate (2,000/125 mg) in Acute Bacterial Rhinosinusitis caused by Streptococcus Pneumoniae , Including Penicillin-Resistant Strains
A pooled efficacy analysis of two multinational, nonrandomized trials shows that a pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) given as two 1000/62.5 mg tablets twice daily is highly effective for treating acute bacterial rhinosinusitis caused by Streptoco…
DOI: 10.1177/014556130608500812